Capromorelin Patent Expiration

About Veterinary Capromorelin

Capromorelin is used in a drug marketed by 1 company: Elanco Us Inc.

Other drugs containing Capromorelin are: Entyce , Elura .

Given below is the list of patents protecting Capromorelin, along with the drug name that holds that patent and the company owning that drug.

Filter patents by

Drug Used In	Drug Patent Number	Drug Patent Expiry	Drug Owner

Elura	US9499543	28 May, 2034	ELANCO US INC.
ENTYCE	US6673929	13 Jun, 2022	ELANCO US INC.

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List